Mallinckrodt Guts IP Suit Amid Oxide Rival's New Drug App

By Kelly Lienhard · February 13, 2024, 3:08 PM EST

A Delaware federal judge has dismissed 10 of the originally asserted 14 patents in pharmaceutical company Mallinckrodt's claims against a French industrial gas company over a generic version of its pediatric...

To view the full article, register now.